Benchmark Holdings PLC Launch of breakthrough purification system
16 August 2017 - 4:00PM
RNS Non-Regulatory
TIDMBMK
Benchmark Holdings PLC
16 August 2017
Benchmark Holdings plc
("Benchmark" or the "Company")
Benchmark pioneers environmentally benign purification system in
the fight against sealice
Benchmark is pleased to announce it has developed a major
industry breakthrough for the salmon industry, CleanTreat, a new
fully contained purification system. Chemical based bath treatments
that are released into water are one of the biggest objections to
the salmon farming industry and CleanTreat works to solve this
environmental challenge.
CleanTreat ensures the safe use of compounds in the marine
environment by purifying the medicine from the treatment water to
undetectable levels. The CleanTreat system is the first of its kind
to be used in aquaculture, and will be administered in conjunction
with Benchmark's next generation sealice treatment, which is
currently in late stage development. The system can also be used
with most licensed bath treatments.
CleanTreat is packaged in a standard ISO shipping container
which allows for modular installation on board well-boats,
treatment barges and land based systems. The system ensures that
treatment water is purified and detached lice will be filtered and
collected, achieving the highest level of environmental safety and
also reducing the risk of future development of resistance.
The treatment plan will firstly be launched in the Norwegian
market. The trials will see leading producers pilot the new system
and product at commercial scale. The worldwide market for salmon is
estimated to be worth 10.7bn USD per annum and the estimated cost
of sealice for the global market is estimated to be 1bn USD.
Malcolm Pye, CEO of Benchmark commented:
"Sea lice are a major challenge for the sustainable growth of
the salmon industry. Our main objective as a company is to produce
innovative treatments which ensure the good health and welfare of
farmed fish, that are highly efficacious and have no significant
impact on the environment."
"The Benchmark Group has a growing toolkit of products and
services, such as CleanTreat, alongside the launch in 2015 of
sealice resistant salmon strains. Whilst there is no single 'silver
bullet' to combat the sealice problem, Benchmark continues to
invest in a range of new technologies to tackle the sea lice
challenge, including biological control such as lumpfish production
and vaccine development".
-ENDS-
Benchmark Holdings plc Tel: 020 7920 3150
Malcolm Pye, CEO
Rachel Aninakwah, Communications
Numis Tel: 020 7260 1000
Michael Meade / Freddie Barnfield
(NOMAD)
James Black (Corporate Broking)
Tavistock Tel: 020 7920 3150
Niall Walsh / Sophie Praill
/ Simon Hudson
Notes to Editors:
Benchmark challenges the status quo in aquaculture, agriculture
and animal healthcare.
Since 2000, Benchmark has consistently worked to build a
platform to serve its customers, helping farmers to take control of
their biological environment through the combination of genetics,
nutrition, health and knowledge services. Through its in-depth
knowledge of animal biology Benchmark is able to tackle the key
issues in the aquaculture, livestock and companion animal
sectors.
The Company has proven distribution capabilities in high growth
markets and operates internationally with R&D facilities,
commercial farms, diagnostic laboratories, manufacturing sites,
production facilities and commercial offices across 27 countries in
five continents. As at 30 June 2017, Benchmark employed 951
people.
For further information on Benchmark please visit
www.benchmarkplc.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRAPAMRTMBTBBMR
(END) Dow Jones Newswires
August 16, 2017 02:00 ET (06:00 GMT)
Benchmark (LSE:BMK)
Historical Stock Chart
From Apr 2024 to May 2024
Benchmark (LSE:BMK)
Historical Stock Chart
From May 2023 to May 2024